← Eichor
Study identifier: NCT07341984 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Physiotherapy Intervention Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

Condition: Amyotrophic Lateral Sclerosis  ·  Sponsor: Charlotte Vogt

PhaseNA
Planned participants38
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

This study investigates whether an individualized physiotherapy program, tailored to each patient's specific motor deficits, can better support physical function compared with usual care physiotherapy in people with ALS. The individualized program is guided by diagnostic assessments using a robotic leg press system, which helps identify strengths and weaknesses in muscle function and movement control. Participants will receive either individualized physiotherapy or standard physiotherapy and will be followed for 12 months. The aim of the study is to improve physiotherapy strategies for people with ALS in a safe and patient-centered manner.

This description comes directly from the study's public registry record.

Talk to the study team

Charlotte Vogt  ·  0041714943581  ·  charlotte.vogt@h-och.ch

Oleksandra Hoptar  ·  0041714943581  ·  oleksandra.hoptart@h-och.ch

Always discuss trial participation with your own doctor first.

Locations (1)

ALS ClinicSankt Gallen, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07341984